Hedyeh Ebrahimi
Papers
1
Total Citations
1
H-Index
1
About
Hedyeh Ebrahimi is a rising researcher in urologic oncology, with a focused expertise in muscle-invasive bladder cancer (MIBC) and the precision of surgical staging. Her work critically addresses the challenge of staging inaccuracies in MIBC, which can lead to significant undertreatment or overtreatment for patients. In her highly cited 2025 paper, she investigates clinical and pathological predictors of pathologic upstaging at radical cystectomy, specifically stratifying outcomes by neoadjuvant chemotherapy receipt. This contribution provides vital insights for refining treatment strategies in robot-assisted radical cystectomy, helping to identify which patients are most at risk for disease progression. While her citation count is still building—a natural stage for an early-career researcher—her work is already shaping clinical decision-making in a high-stakes area of oncology. Ebrahimi’s research bridges the gap between pathology and surgical planning, offering a roadmap for more personalized, stage-appropriate care in bladder cancer. Her dedication to improving prognostic accuracy marks her as a promising voice in the future of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1